Center-Authored Papers

Filters: Author is Redman, Mary  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Allen JW, Moon J, Redman M, Gadgeel SM, Kelly K, Mack PC, Saba HM, Mohamed MK, Jahanzeb M, Gandara DR.  2014.  Southwest Oncology Group S0802: A Randomized, Phase II Trial of Weekly Topotecan With and Without Ziv-Aflibercept in Patients With Platinum-Treated Small-Cell Lung Cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Abstract
C
Chen Y, Moon J, Pandya KJ, Lau DHM, Kelly K, Hirsch FR, Gaspar LE, Redman M, Gandara DR.  2013.  A Pilot Study (SWOG S0429) of Weekly Cetuximab and Chest Radiotherapy for Poor-Risk Stage III Non-Small Cell Lung Cancer.. Frontiers in oncology. 3:219. Abstract
Cohen SA, Yu M, Baker K, Redman M, Wu C, Heinzerling TJ, Wirtz RM, Charalambous E, Pentheroudakis G, Kotoula V et al..  2017.  The CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastases.. Clinical epigenetics. 9:46. Abstract
F
Ferreira BP, Redman M, Baker KK, Martins R, Eaton KD, Chow LQM, Baik CS, Goulart B, Lee SM, Santana-Davila R et al..  2016.  Predictors of outcome with cetuximab and paclitaxel for head and neck squamous cell carcinoma.. The Laryngoscope. Abstract
G
Gandara DR, Redman M, Hirsch FR.  2015.  Postprogression Prolongation of Survival in EGFR-Mutated Lung Cancer: Reconciling the ASPIRATION and IMPRESS Trials.. JAMA oncology. :1-2.
J
Johnson BA, Long Q, Huang Y, Chansky K, Redman M.  2016.  Model selection and inference for censored lifetime medical expenditures.. Biometrics. 72(3):731-741. Abstract
M
McGregor BA, Syrjala KL, Dolan ED, Langer SL, Redman M.  2012.  The effect of pre-transplant distress on immune reconstitution among adult autologous hematopoietic cell transplantation patients.. Brain, behavior, and immunity. Abstract
S
Smith SD, Redman M, Dunleavy K.  2015.  FDG PET-CT in follicular lymphoma: a case-based evidence review.. Blood. 125(7):1078-82. Abstract
W
West HL, Moon J, Wozniak AJ, Mack P, Hirsch FR, Bury MJ, Kwong M, Nguyen DD, Moore DF, Miao J et al..  2017.  Paired Phase II Studies of Erlotinib/Bevacizumab for Advanced Bronchioloalveolar Carcinoma or Never Smokers With Advanced Non-Small-cell Lung Cancer: SWOG S0635 and S0636 Trials.. Clinical lung cancer. Abstract